5336-53-8N-Nitrosodibenzylamine (NDBzA)

● In Stock

Catalogue No.:	VE006123
CAS No.:	5336-53-8
Mol. Formula:	C14H14N2O
Mol. Weight:	226.27 g/mol

Request a quote

Add to RFQ list

Additional information on CAS 5336-53-8

Parent drug

Noradrenaline

IUPAC Name

N-Nitroso-N-(phenylmethyl)benzenemethanamine

Pharmacopoeial Synonyms

N/A

Other Synonyms

Dibenzylnitrosamine; N,N-Dibenzylnitrosamine; N,N-dibenzylnitrous amide; N-Nitrosodibenzenemethanamine; 1,1-Dibenzyl-2-oxohydrazine

Smile

O=NN(CC1=CC=CC=C1)CC2=CC=CC=C2

InChI

InChI=1S/C14H14N2O/c17-15-16(11-13-7-3-1-4-8-13)12-14-9-5-2-6-10-14/h1-10H,11-12H2

Shipping Condition

Ambient Temperature

Characterization Data (Included)

HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, and Structure Elucidation Report (SER).

Additional Characterization Data

QNMR, D2O Exchange, 13C NMR, 13C APT, COSY NMR, NOESY NMR, 15N NMR, HSQC NMR, HMQC NMR, and HMBC NMR. These are available upon request and may be free or subject to additional charges.

Description

N-Nitrosodibenzylamine is an N-nitroso derivative of the secondary amine | which is a highly characterized reference material that meets stringent regulatory standards set for nitrosamine compounds | including those set by USP | EMA | JP | and BP. This nitroso standard is essential for a variety of applications | such as analytical method development | method validation (AMV) | and Quality Control (QC) | particularly in the context of API and raw material production. It is suitable for use in both Abbreviated New Drug Applications (ANDA) and New Drug Applications (NDA). This nitrosamine standard helps establish detection limits | quantify impurity levels | and ensure trace nitroso impurities in pharmaceutical products remain within FDA and EMA safety limits.